181 related articles for article (PubMed ID: 32762249)
1. The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in Germany.
Seddik AH; Branner JC; Ostwald DA; Schramm SH; Bierbaum M; Katsarava Z
Cephalalgia; 2020 Dec; 40(14):1551-1560. PubMed ID: 32762249
[TBL] [Abstract][Full Text] [Related]
2. Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort Approach.
Seddik AH; Schiener C; Ostwald DA; Schramm S; Huels J; Katsarava Z
Value Health; 2021 Oct; 24(10):1446-1453. PubMed ID: 34593167
[TBL] [Abstract][Full Text] [Related]
3. Annual indirect costs secondary to headache disability in Brazil.
Oliveira AB; Queiroz LP; Sampaio Rocha-Filho P; Sarmento EM; Peres MF
Cephalalgia; 2020 May; 40(6):597-605. PubMed ID: 31757169
[TBL] [Abstract][Full Text] [Related]
4. Burden and costs of migraine in a Swedish defined patient population - a questionnaire-based study.
Hjalte F; Olofsson S; Persson U; Linde M
J Headache Pain; 2019 May; 20(1):65. PubMed ID: 31151382
[TBL] [Abstract][Full Text] [Related]
5. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
Shimizu T; Sakai F; Miyake H; Sone T; Sato M; Tanabe S; Azuma Y; Dodick DW
J Headache Pain; 2021 Apr; 22(1):29. PubMed ID: 33882816
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
Lublóy Á
BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
[TBL] [Abstract][Full Text] [Related]
8. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia.
Wong LP; Alias H; Bhoo-Pathy N; Chung I; Chong YC; Kalra S; Shah ZUBS
J Headache Pain; 2020 Jun; 21(1):68. PubMed ID: 32513174
[TBL] [Abstract][Full Text] [Related]
9. The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable.
Husøy A; Katsarava Z; Steiner TJ
J Headache Pain; 2023 Feb; 24(1):7. PubMed ID: 36782131
[TBL] [Abstract][Full Text] [Related]
10. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract][Full Text] [Related]
11. The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State.
Rao GN; Kulkarni GB; Gururaj G; Stovner LJ; Steiner TJ
J Headache Pain; 2015; 16():94. PubMed ID: 26553066
[TBL] [Abstract][Full Text] [Related]
12. Indirect costs attributed to headache: A nation-wide survey of an active working population.
Gil-Gouveia R; Miranda R
Cephalalgia; 2022 Apr; 42(4-5):317-325. PubMed ID: 34521261
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project.
Rastenytė D; Mickevičienė D; Stovner LJ; Thomas H; Andrée C; Steiner TJ
J Headache Pain; 2017 Dec; 18(1):53. PubMed ID: 28474253
[TBL] [Abstract][Full Text] [Related]
14. Productivity losses attributable to headache, and their attempted recovery, in a heavy-manufacturing workforce in Turkey: implications for employers and politicians.
Selekler HM; Gökmen G; Alvur TM; Steiner TJ
J Headache Pain; 2015; 16():96. PubMed ID: 26573819
[TBL] [Abstract][Full Text] [Related]
15. The cost of headache disorders in Europe: the Eurolight project.
Linde M; Gustavsson A; Stovner LJ; Steiner TJ; Barré J; Katsarava Z; Lainez JM; Lampl C; Lantéri-Minet M; Rastenyte D; Ruiz de la Torre E; Tassorelli C; Andrée C
Eur J Neurol; 2012 May; 19(5):703-11. PubMed ID: 22136117
[TBL] [Abstract][Full Text] [Related]
16. Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey.
García-Azorín D; Moya-Alarcón C; Armada B; Sánchez Del Río M
J Headache Pain; 2024 Mar; 25(1):38. PubMed ID: 38486155
[TBL] [Abstract][Full Text] [Related]
17. Healthcare resource use and indirect costs associated with migraine in Italy: results from the
Martelletti P; Schwedt TJ; Vo P; Ritrovato D; Reilly MC; Naclerio M; Ranjan P; Kleebach J; Joshi P
J Med Econ; 2021; 24(1):717-726. PubMed ID: 33955821
[TBL] [Abstract][Full Text] [Related]
18. Migraine and reduced work performance: a population-based diary study.
Von Korff M; Stewart WF; Simon DJ; Lipton RB
Neurology; 1998 Jun; 50(6):1741-5. PubMed ID: 9633720
[TBL] [Abstract][Full Text] [Related]
19. Headache and migraine: a leading cause of absenteeism.
Baigi K; Stewart WF
Handb Clin Neurol; 2015; 131():447-63. PubMed ID: 26563803
[TBL] [Abstract][Full Text] [Related]
20. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
